Highlights of this issue
A neurobiological hypothesis for the classification of schizophrenia : type A (hyperdopaminergic) and type B (normodopaminergic)
Stages of Mental Illness–psychiatry in pictures
Prescription of antipsychotics in people with dementia†
Use of medication for challenging behaviour in people with intellectual disability
Anti-basal ganglia antibodies in primary obsessive–compulsive disorder : systematic review and meta-analysis
The Man with the Wooden Leg – poem
Developmental pathways from childhood conduct problems to early adult depression : findings from the ALSPAC cohort
Relationship between obesity and the risk of clinically significant depression : Mendelian randomisation study
Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode : 3-year prospective longitudinal study
Impact of depressive episodes on cognitive deficits in early bipolar disorder : data from the Systematic Treatment Optimization Programme for Early Mania (STOP-EM)
Randomised controlled trials – in 100 words
Comparative mortality risks of antipsychotic medications in community-dwelling older adults*,†
Effects of a mindfulness-based psychoeducation programme for Chinese patients with schizophrenia : 2-year follow-up
Insight, duration of untreated psychosis and attachment in first-episode psychosis : prospective study of psychiatric recovery over 12-month follow-up
Activity and views of service users involved in mental health research : UK survey
The UN Convention on the Rights of Persons with Disabilities and UK mental health legislation
The UN Convention on the Rights of Persons with Disabilities and UK mental health legislation
The UN Convention on the Rights of Persons with Disabilities and UK mental health legislation
The significance of copy number variations in schizophrenia
The significance of copy number variations in schizophrenia
Getting real about risk
Getting real about risk
On Depression. Drugs, Diagnosis and Despair in the Modern World
From the Editor's desk